[1]
I. C. Jacobsen, T. Berg, M.-B. Jensen, and A. S. Knop, “Outcomes for patients with high-risk ER-positive, HER2-negative early-stage breast cancer: a Danish real-world study”, AO, vol. 64, pp. 1531–1539, Nov. 2025.